Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery

Chang Gung Medical Foundation

Status: Completed

Conditions: Colorectal Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT07289685

CMRPG3M2171 (Other Grant/Funding Number)

202102412B0

Details and patient eligibility

About

This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement.

Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs.

Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care.

The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.

Enrollment: 192 patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients undergoing minimally invasive colorectal tumor resection.
2. Aged 20 to 85 years.
3. ECOG score 0-2.
4. Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
5. Informed consent provided by the patient or family.

Exclusion criteria

1. Patients with acute/chronic psychiatric disorders or cognitive impairment.
2. Patients undergoing traditional open or local resection surgeries.

Trial design

192 participants in 1 patient group

Postoperative Colorectal Cancer Patients with Wearable Device Monitoring

Description:

Patients diagnosed with colorectal cancer who underwent minimally invasive surgery. Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge.